Stem Cell Therapeutic and Research Reauthorization Act of 2025

# Stem Cell Therapeutic and Research Reauthorization Act of 2025 - Summary **What the Bill Does** This bill would reauthorize federal funding and oversight for stem cell research and therapeutic development. Stem cells are special cells that can develop into different cell types in the body, making them valuable for treating diseases and injuries. The bill would extend or renew existing programs, authorities, and funding mechanisms related to how the federal government supports and regulates this research. **Who It Affects and Key Details** The bill would primarily affect researchers at universities and medical institutions, biotech companies developing stem cell treatments, and patients who might benefit from resulting therapies.

It would influence how federal agencies like the National Institutes of Health manage stem cell research funding and what types of research can receive federal dollars. The specific provisions aren't detailed in the available information, but reauthorization bills typically renew expiring authorities, adjust funding levels, or modify program requirements. **Current Status** As of now, the bill is in committee, meaning it's in the early stages of the legislative process and hasn't yet been debated or voted on by the full House of Representatives. The bill was introduced by Representative Christopher Smith (R-NJ).